The Hydroxyzine Pamoate Capsules, cataloged under National Stock Number 6505-00-765-0824, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Zenith Laboratories Inc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 5 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-00-765-0824 |
| Primary Part Number | NDC00172-2909-70 |
| Item Name | Hydroxyzine Pamoate Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Zenith Laboratories Inc |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 500.000 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00172-2909-70 PRIMARY | Zenith Laboratories Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00536-3894-05 | 5/9 Secondary reference Rugby Group Inc |
| NDC00364-0484-05 | 5/9 Secondary reference Henry Schein, Inc. |
| NDC00364-0484-05 | 5/9 Secondary reference Schein Henry Inc |
| NDC54868-1854-04 | 5/9 Secondary reference Medical and Safety Group Inc Dba Industrial Drug Service |
| NDC52544-0801-05 | 3/9 Design control — primary reference Watson Labs Inc |
NSN 6505-00-765-0824 is a Hydroxyzine Pamoate Capsules, manufactured by Zenith Laboratories Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-765-0824 has 1 manufacturer part number on file: NDC00172-2909-70 (Zenith Laboratories Inc).
Key specifications for NDC00172-2909-70: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: 50 MG HYDROXYZINE HYDROCHLORIDE EQUIVALENT; Capsule Primary Container Content Quantity: 500.000. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.